The Cell Cycle Molecules Behind Neurodegeneration in Alzheimer's Disease: Perspectives for Drug Development

E-ISSN： 1875-533x|15|24|2420-2432

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.15, Iss.24, 2008-10, pp. : 2420-2432

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Modelling neurodegeneration in prion disease – applications for drug development

By Uppington Kay M Brown David R

Expert Opinion on Drug Discovery, Vol. 2, Iss. 6, 2007-06 ,pp. : 777-788

Informa Healthcare

Access to resources Recommend Favorite

Huprines for Alzheimer's disease drug development

By Muñoz-Torrero Diego Camps Pelayo

Expert Opinion on Drug Discovery, Vol. 3, Iss. 1, 2008-01 ,pp. : 65-81

Informa Healthcare

Access to resources Recommend Favorite

Drug Treatments in Development for Alzheimer's Disease

JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol. 42, Iss. 1, 2012-03 ,pp. : 58-65

John Wiley & Sons Inc

Access to resources Recommend Favorite

The Cell Cycle and Hormonal Fluxes in Alzheimer Disease: A Novel Therapeutic Target

Current Pharmaceutical Design, Vol. 12, Iss. 6, 2006-02 ,pp. : 691-697

Bentham Science Publishers

Access to resources Recommend Favorite

The Expression of Cell Cycle Proteins in Neurons and its Relevance for Alzheimer's Disease

Current Drug Targets-CNS & Neurological Disorders, Vol. 4, Iss. 3, 2005-06 ,pp. : 293-306

Bentham Science Publishers

Access to resources Recommend Favorite